CIK 0001178253
- Non-accelerated filer
- Smaller reporting company
SCYNEXIS INC
Sign in to watch- Ticker
- SCYX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 562181648
- Phone
- +1 201-884-5485
- Business address
- 1 EVERTRUST PLAZA, 13TH FLOOR, JERSEY CITY, NJ, 07302-6548
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 76 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-01 | Angulo Gonzalez David Chief Executive Officer | Purchase | +108,695 | 1,357,126 | ||
| 2026-04-01 | Angulo Gonzalez David Chief Executive Officer | Purchase · Warrant to Purchase Common Stock | +108,695 | 108,695 | ||
| 2026-01-29 | Angulo Gonzalez David Chief Executive Officer | Grant or award | +391,333 | 1,244,431 | ||
| 2025-10-17 | Angulo Gonzalez David Chief Executive Officer | Grant or award | +32,500 | $0.76 | $25K | 853,098 |
| 2025-04-09 | Angulo Gonzalez David Chief Executive Officer | Grant or award | +23,000 | $0.84 | $19K | 816,598 |
| 2025-03-20 | Angulo Gonzalez David Chief Executive Officer | Grant or award | +13,800 | $1.05 | $14K | 793,598 |
| 2025-03-19 | Angulo Gonzalez David Chief Executive Officer | Grant or award | +5,000 | $1.07 | $5K | 779,798 |
| 2025-01-23 | Angulo Gonzalez David Chief Executive Officer | Grant or award | +262,927 | 770,798 | ||
| 2025-01-23 | Angulo Gonzalez David Chief Executive Officer | Grant or award · Employee Stock Option (Right to Buy) | +394,391 | 394,391 | ||
| 2024-09-12 | Angulo Gonzalez David Chief Executive Officer | Purchase | +20,000 | $1.37 | $27K | 507,871 |
| 2024-01-26 | Angulo Gonzalez David Chief Executive Officer | Grant or award | +290,590 | 479,871 | ||
| 2024-01-26 | Angulo Gonzalez David Chief Executive Officer | Grant or award · Employee Stock Option (Right to Buy) | +431,030 | 431,030 | ||
| 2023-01-01 | Angulo Gonzalez David Chief Executive Officer | Grant or award | +110,000 | 185,181 | ||
| 2023-01-01 | Angulo Gonzalez David Chief Executive Officer | Grant or award · Employee Stock Option (Right to Buy) | +165,000 | 165,000 | ||
| 2022-02-04 | Angulo Gonzalez David Chief Medical Officer | Grant or award | +51,100 | 74,981 | ||
| 2022-02-04 | Angulo Gonzalez David Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +85,000 | 85,000 | ||
| 2021-01-29 | Angulo Gonzalez David Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2020-12-21 | Angulo Gonzalez David Chief Medical Officer | Purchase | +1,600 | $6.25 | $10K | 23,780 |
| 2020-12-21 | Angulo Gonzalez David Chief Medical Officer | Grant or award · Common Stock Warrant | +800 | 800 | ||
| 2020-12-21 | Angulo Gonzalez David Chief Medical Officer | Grant or award · Common Stock Warrant | +800 | 800 |
Page 1 of 2 · 39 trades